军医进修学院学报2011，Vol.32Issue(5)：418-419,482,3.DOI:CNKI:11-3275/R.20101208.1603.004
以腋窝淋巴结转移为首发症状的隐性乳腺癌诊治分析
Diagnosis and treatment of occult breast cancer with axillary lymph node metastasis as its primary clinical feature
李捷 1张艳君 1王建东 1李席如1
作者信息
- 1. 解放军总医院普通外科,北京,100853
- 折叠
摘要
Abstract
Objective To study the diagnosis and treatment of occult breast cancer(OBC) with axillary lymph node metastasis as its primary clinical feature. Methods Clinical data about 12 OBC patients with axillary nodal metastasis as its primary clinical feature admitted to our hospital in January 2000- February 2009 were retrospectively analyzed. Of these patients, 9 underwent breast magnetic resonance imaging of breast and axillary fossa. All patients underwent thyroid, thoracic and abdominal CT or PET-CT scanning before operation to exclude metastasis in other organs. Of the 12 patients, 9 underwent axillary lymph node dissection and 3 underwent modified radical mastectomy. The biopsy samples were examined with immunohistochemistry. Of the 12 patients, 3 underwent radiotherapy and 5 underwent endocrine therapy after operation. The longest and shortest follow-up time of the patients was 10 years and 1 year, respectively. Results OBC accounted for 0.77% in 1 550 breast cancer patients admitted to our hospital in January 2000- February 2009. Of the 12 OBC patients, 2 was diagnosed with infiltrating ductal carcinoma, 1 was diagnosed with infiltrating micropapillary carcinoma, with no foci observed in breast of the remaining 9 patients. The patients were followed up after operation, during which local recurrence was found in 1 patient and no distant metastasis occurred. Conclusion MRI is of great importance in diagnosis of OBC. Chemotherapy and neoadjuvant chemotherapy in combination with axillary lymph node dissection or modified radical mastectomy are the choice of treatment modalities for OBC.关键词
隐性乳腺癌/腋窝淋巴结转移Key words
Occult Breast Cancer/ Axillary Lymph Node Metastases分类
医药卫生引用本文复制引用
李捷,张艳君,王建东,李席如..以腋窝淋巴结转移为首发症状的隐性乳腺癌诊治分析[J].军医进修学院学报,2011,32(5):418-419,482,3.
